Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / IBD BREAKOUT
-
Total 13F shares
-
41,601
-
Share change
-
-40,232
-
Total reported value
-
$1,230,079
-
Price per share
-
$29.58
-
Number of holders
-
8
-
Value change
-
-$1,167,798
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q4 2022
As of 31 Dec 2022,
INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,601 shares.
The largest 8 holders included
CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ADVISOR GROUP HOLDINGS, INC., UBS Group AG, Asset Dedication, LLC, BENJAMIN F. EDWARDS & COMPANY, INC., HOLLENCREST CAPITAL MANAGEMENT, and AdvisorNet Financial, Inc.
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.